Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal, also known as retinaldehyde, is a vital polyene chromophore and a derivative of Vitamin A that serves as the primary light-sensing molecule in the vertebrate eye [1, 2]. It exists in several isomeric forms, with 11-cis-retinal being the form that covalently binds to opsin proteins within photoreceptor cells to form visual pigments like rhodopsin [3]. Upon the absorption of light, 11-cis-retinal undergoes a rapid isomerization to all-trans-retinal, a process that triggers a conformational change in the associated G protein-coupled receptor and initiates the phototransduction cascade [1, 4]. This molecular switch is essential for converting light energy into electrical signals that the brain interprets as vision [2]. Beyond its physiological role, retinal is central to the pathogenesis of various retinal dystrophies and age-related ocular conditions [5]. The accumulation of all-trans-retinal or its toxic condensation products, such as A2E, is a hallmark of diseases like Stargardt disease and age-related macular degeneration [3, 6]. Consequently, the visual cycle—the metabolic pathway responsible for regenerating 11-cis-retinal—is a major focus for therapeutic intervention [5]. Drugs such as emixustat and fenretinide aim to modulate this cycle to reduce the production of toxic retinal byproducts and preserve vision in patients with degenerative retinal diseases [6, 7]. Sources: [1] PubChem. Retinal. https://pubchem.ncbi.nlm.nih.gov/compound/Retinal [2] Wikipedia. Retinal. https://en.wikipedia.org/wiki/Retinal [3] Kiser, P. D., et al. (2014). Chemistry of the Retinoid (Visual) Cycle. Chemical Reviews. https://doi.org/10.1021/cr400107q [4] Palczewski, K. (2006). G protein-coupled receptors: rhodopsin. Annual Review of Biochemistry. https://doi.org/10.1146/annurev.biochem.75.103004.142743 [5] Travis, G. H., et al. (2007). The visual cycle: genes and diseases. Annual Review of Genetics. https://doi.org/10.1146/annurev.genet.41.110306.130225 [6] Bavik, C., et al. (2015). Visual cycle modulators: a review. Journal of Clinical Medicine. https://doi.org/10.3390/jcm4071469 [7] Radu, R. A., et al. (2005). Fenretinide prevents vitamin A-mediated lipofuscin accumulation. Archives of Ophthalmology. https://doi.org/10.1001/archopht.123.6.788
Acts as a light-sensitive prosthetic group for opsin proteins; undergoes 11-cis to all-trans isomerization upon photon absorption to activate phototransduction signaling cascades.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal (Retinaldehyde) (RAL).